Cryopyrin-associated periodic syndromes and autoinflammation

Clinical and Experimental Dermatology

Volumn 33, Issue 1, 2008, Pages 1-9

  Shinkai, K ^a   McCalmont, T H ^a   Leslie, K S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; COLCHICINE; CORTICOSTEROID DERIVATIVE; CRYOPYRIN; CYCLOSPORIN; CYTOKINE; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 1; MERCAPTOPURINE; MESALAZINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; PROTEIN CIAS 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIMVASTATIN; STEROID; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANEMIA; AUTOINFLAMMATORY DISEASE; BLAU SYNDROME; CHRONIC INFLAMMATION; CINCA SYNDROME; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CROHN DISEASE; CRYOPYRIN ASSOCIATED PERIODIC SYNDROME; CYTOKINE PRODUCTION; DISEASE SEVERITY; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; MUCKLE WELLS SYNDROME; NEUTROPHIL CHEMOTAXIS; ORGAN INJURY; PAPA SYNDROME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URTICARIA;

AGE OF ONSET; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MUTATION; PERIODICITY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SYNDROME; URTICARIA;

EID: 37349036932     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02540.x     Document Type: Review

References (31)

1. Kile RL, Rusk HA. A case of cold urticaria with unusual family history. JAMA 1940 114 : 1067 8.
2. Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. Q J Med 1962 31 : 235 48.
3. Hoffman HM, Mueller JL, Broide DH et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001 29 : 301 5.
4. Dode C, Le Du N, Cuisset L et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 2002 70 : 1498 506.
5. Feldmann J, Prieur AM, Quartier P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002 71 : 198 203.
6. Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediat 1981 99 : 79 83.
7. Leslie KS, Lachmann HJ, Bruning E et al. Phenotype, genotype and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/ NALP3 mutations. Arch Dermatol 2006 142 : 1591 7.
8. Kilcline C, Shinkai K, Bree A et al. Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol 2005 141 : 248 53.
9. Agostini L, Martion F, Burns K et al. NALP3 forms an IL-1 beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004 20 : 319 25.
10. Ozen S, Hoffman HM, Frenkel J, Kastner D. Familial Mediterranean fever (FMF) and beyond: a new horizon. Ann Rheum Dis 2006 16 : 665 70.
11. Huttenlocher A, Frieden IJ, Emery H. Neonatal onset multisystem inflammatory disease. J Rheumatol 1995 22 : 1171 3.
12. Prieur AM. A recently recognized chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001 19 : 103 6.
13. Aksentijevich I, Nowak M, Mallah M et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002 46 : 3340 8.
14. Aganna E, Martinon F, Hawkins PN et al. Association of mutations in the NALP3/ CIAS1/ PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002 46 : 2445 52.
15. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004 50 : 607 12.
16. Hoffman HM, Patel DD. Genomic-based therapy: targeting interleukin-1 for autoinflammatory diseases. Arthritis Rheum 2004 50 : 345 9.
17. Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004 364 : 1779 85.
18. Ramos E, Arostegui JI, Campuzano S et al. Positive clinical and biochemical responses to anakinra in a 3-year-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology 2005 44 : 1072 3.
19. Goldbach-Mansky R, Dailey NJ, Canna SW et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006 355 : 581 92.
20. Sutterwala FS, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006 24 : 317 27.
21. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004 117 : 561 74.
22. Mariathasan S, Weiss DS, Newton K et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440 : 228 32.
23. Martinon F, Petrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 440 : 237 41.
24. Kanneganti TD, Ozoren N, Body-Malapel M et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006 440 : 233 6.
25. Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004 14 : 1929 34.
26. Kanneganti TD, Body-Malapel M, Amer A, et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006 281 : 36560 8.
27. Johnston JB, Barrett JW, Nazarian SH et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005 23 : 587 98.
28. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005 17 : 586 99.
29. Touitou I, Lesage S, McDermott M et al. Infevers: an evolving mutation database for autoinflammatory syndromes. Hum Mutat 2004 24 : 194 8.
30. Shinkai K, Kilcline C, Connolly MK, Frieden IJ. The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease. Arch Dermatol 2006 141 : 242 7.
31. Federico G, Rigante D, Publiese AL, Ranno O et al. Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol 2003 32 : 312 14.